Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Peritoneal Neoplasms 2Mesothelioma, Malignant 2Adrenocortical Carcinoma 2Thrombocytopenia 1Stomach Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoma 1Laryngeal Neoplasms 1Intraocular Lymphoma 1Hypopharyngeal Neoplasms 1Hyperthermia 1Glioma 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Carcinoma 1Adenocarcinoma 1

Interventions

Rituximab 8Cyclophosphamide 8Peripheral Blood Stem Cell Transplantation 7Methotrexate 7fludarabine phosphate 6Whole-Body Irradiation 5Tacrolimus 5Mycophenolic Acid 5Dexamethasone 5Cyclosporine 5Cytarabine 4Transplantation 3Radiotherapy 3Filgrastim 3Busulfan 3pegfilgrastim 2merphos 2etoposide phosphate 2Methylprednisolone 2Lenalidomide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Carboplatin 2Calcium Dobesilate 2Antilymphocyte Serum 2zanubrutinib 1sodium thiosulfate 1sargramostim 1oblimersen 1ibrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Intraocular Lymphoma × sodium thiosulfate × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡